What is pneumococcal pneumonia?
A lung infection by a common bacteria called Streptococcus pneumoniae
An infection spreading from person to person through talking, coughing, or close contact
A life-threatening infection potentially requiring admission to the hospital or intensive care unit
PREVNAR 20 is not indicated to reduce complications of pneumococcal diseases, such as hospitalization and death.
Who’s at risk of pneumococcal pneumonia?
Adults 50+
were observed to be at increased risk in studies
Adults 18+
with one of these conditions were observed to be at increased risk in studies:†
Diabetes
3X risk
increase vs.
healthy adults
Smoking
3–4X risk
increase vs.
healthy adults
Chronic heart
disease
4–5X risk
increase vs.
healthy adults
Chronic
lung disease‡
4–10X risk
increase vs.
healthy adults
‡ Including asthma and COPD
Other conditions were observed to increase the risk of
pneumococcal pneumonia in studies:
COPD=chronic obstructive pulmonary disease; IPD=invasive pneumococcal disease.
† Using information from American healthcare databases from 2006 to 2010, rates of pneumococcal disease were compared in immunocompetent adults with chronic medical conditions, immunocompromised adults, and in adults without these conditions. Risk profiles and episodes of pneumococcal disease—all-cause pneumonia, pneumococcal pneumonia, and IPD—were established according to diagnosis, procedure, and drug codes.
It may be vaccine-preventable
One dose of the PREVNAR 20 vaccine can help prevent pneumococcal pneumonia.
PREVNAR 20 is a vaccine to help protect against pneumococcal pneumonia caused by 20 types of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F).
* Fictional case. May not be representative of the general population.
PREVNAR 20™ is a pneumococcal vaccine that helps protect against certain diseases such as pneumonia, bacteremic pneumonia, sepsis or bacteremia and meningitis caused by 20 types of the bacteria Streptococcus pneumoniae in adults 18 years and older.
PREVNAR 20 will only protect against diseases caused by the types of Streptococcus pneumoniae bacteria covered by the vaccine and it does not reduce complications of pneumococcal disease, such as hospitalization.
PREVNAR 20 should not be used if you are allergic (hypersensitive) to the active substances, to any other ingredients, or to any other vaccine that contains diphtheria toxoid.
Take special care with PREVNAR 20:
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your healthcare professional for advice before receiving this vaccine.
Common side effects reported in more than 1 in 100 individuals, and up to 1 in 10 individuals, are swelling/redness at the injection site and fever. Uncommon side effects in more than 1 in 1000 individuals, and up to 1 in 100 individuals, are allergic reactions (including swelling, shortness of breath, wheezing), diarrhea, nausea, vomiting, rash and swelling of the face/lips/mouth/tongue/throat which may cause difficulty in swallowing or breathing, itching/hives at the injection site, swollen glands in the neck/armpit/groin, and chills. The following side effects were seen with PREVNAR 13, and may also be seen with PREVNAR 20: severe allergic reaction, shock, or cardiovascular collapse; swelling of lips, face, or throat, enlarged lymph nodes or glands near the vaccination site, hives, redness and irritation, and itching at the injection site, and a rash causing itchy red blotches.
As with any vaccine, PREVNAR 20 will not protect 100% of those who receive the vaccine.
To learn more, visit PREVNAR20.ca
DIN: 02527049
* Fictional case. May not be representative of the general population.
